Analyst Consensus ?
ConsensusHold43 ratings
Bullish2046.5%
Neutral2046.5%
Bearish37.0%
PulteGroup, Inc. · PHM · FY2025 Q3 · Calendar Q4 2025
PulteGroup holds guidance as Del Webb offsets housing-market pressure
The supplied analysis supports a cautiously constructive operating thesis for PulteGroup: active-adult demand, Del Webb expansion, and a strong balance sheet support the business, but elevated spec inventory, incentives, regional gaps, and potential tariff costs limit confidence in durable earnings growth.
Reported Before market openNYSEConsumer Cyclical
$22.34B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$2.96
Consensus $2.89
EPS surprise
+2.4%
Reported versus consensus
Reported revenue
$4.40B
Consensus $4.30B
Revenue surprise
+2.4%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
0.0%
Event window
SPY move
-0.0%
Same window
Abnormal move
+0.0%
Stock minus SPY
Volume
2.1×
Versus trailing sessions
Subsequent drift
-7.9%
Up to 20 sessions
PHMSPY benchmark
Ask FN2 about PHM FY2025 Q3
Transcript, numbers and history already loaded
What drove PHM's +0.0% move after FY2025 Q3 earnings?What changed in PHM's guidance and outlook in FY2025 Q3?Give me the bull and bear case for PHM after FY2025 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Q3 analysis highlighted Del Webb and active-adult demand as continued strengths, while spec inventory reached about 50% of production and incentives rose to 8.9% of sales price. Management introduced Del Webb Explore and cited an estimated roughly $1,500 per-home tariff impact beginning in 2026; full-year guidance was maintained.
Guidance delta
Maintained: full-year closings guidance is 29,000-29,400, ASP guidance is $560,000-$570,000, and Q4 gross-margin guidance is 25.5%-26%.
Key takeaways
- Q3 performance remained strong despite a challenging housing market, with active-adult demand and Del Webb driving growth.
- Management is tightening start-to-sale alignment as spec homes sit around 50% of production, above the 40%-45% target range.
- The Del Webb Explore rollout, disciplined land spending, and continued share repurchases remain central to the operating plan.
Management priorities
- Expand Del Webb Explore communities in 2026.
- Keep land spending around $5 billion while optimizing the land pipeline.
- Reduce the spec-home proportion toward the 40%-45% range and continue the share-repurchase program.
Follow PHM with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$115.73Current
$52Low
$120.67Average
$166High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 3, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Evercore ISI Group | Outperform | Outperform | Maintain | Sep 25, 2026 |
| Truist Securities | Buy | Buy | Maintain | Sep 16, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Sep 11, 2026 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Aug 24, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 24, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 23, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 23, 2026 |
| UBS | Buy | Buy | Maintain | Apr 24, 2026 |
| B of A Securities | Buy | Buy | Maintain | Apr 20, 2026 |
| Seaport Global | Sell | Buy | Downgrade | Apr 7, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 3, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 30, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Jul 23, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jan 14, 2025 |
| Wedbush | Outperform | Neutral | Upgrade | Jan 3, 2025 |
| BTIG | Buy | Buy | Maintain | Oct 23, 2024 |
| Zelman & Assoc | Outperform | Neutral | Upgrade | Apr 24, 2024 |
| Jefferies | Buy | Buy | Maintain | Apr 24, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 26, 2023 |
| Keybanc | Overweight | Overweight | Maintain | Feb 3, 2023 |
| Susquehanna | Positive | Neutral | Upgrade | Oct 23, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | May 12, 2020 |
| CFRA | Hold | Hold | Maintain | Apr 23, 2020 |
| Bank of America | Neutral | Underperform | Upgrade | Jan 7, 2020 |
| Buckingham Research | Neutral | Neutral | Maintain | Oct 24, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Oct 24, 2019 |
| BTIG Research | Neutral | Sell | Upgrade | Apr 24, 2019 |
| Deutsche Bank | Hold | Buy | Downgrade | Oct 22, 2018 |
| Mizuho | Neutral | Buy | Downgrade | Aug 7, 2018 |
| B. Riley FBR | Neutral | Buy | Downgrade | May 5, 2018 |
| B. Riley Securities | Buy | Neutral | Upgrade | Apr 25, 2018 |
| FBR Capital | Buy | Buy | Maintain | Oct 25, 2017 |
| Zelman | Hold | Buy | Downgrade | Apr 4, 2016 |
| Sterne Agee CRT | Neutral | Buy | Downgrade | Dec 22, 2015 |
| Sterne Agee | Neutral | Buy | Downgrade | Dec 22, 2015 |
| Morgan Stanley | Underweight | Equal Weight | Downgrade | Oct 13, 2015 |
| Compass Point | Neutral | Neutral | Maintain | Oct 13, 2014 |
| FBN Securities | Underperform | Sector Perform | Downgrade | Dec 30, 2013 |
| Williams Financial | Buy | Hold | Upgrade | Jul 30, 2013 |
| Williams Capital | Buy | Hold | Upgrade | Jul 30, 2013 |
| ISI Group | Neutral | Strong Buy | Downgrade | Jul 26, 2013 |
| MKM Partners | Neutral | Buy | Downgrade | Jul 16, 2012 |
| Guggenheim | Neutral | Neutral | Maintain | Apr 26, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $115.73. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Adam Kramer | $128 | $116.06 | +10.6% | Oct 1, 2026 |
| Truist Financial | Jonathan Bettenhausen | $136 | $119.47 | +17.5% | Sep 16, 2026 |
| Wells Fargo | Analyst unavailable | $145 | $116.41 | +25.3% | Sep 11, 2026 |
| Wolfe Research | Analyst unavailable | $158 | $129 | +36.5% | Aug 24, 2026 |
| Wolfe Research | Trevor Allinson | $129 | $129 | +11.5% | Aug 24, 2026 |
| UBS | Analyst unavailable | $166 | $123.25 | +43.4% | Jul 23, 2026 |
| RBC Capital | Analyst unavailable | $116 | $123.28 | +0.2% | Jul 23, 2026 |
| Evercore ISI | Analyst unavailable | $162 | $122.5 | +40.0% | Jul 23, 2026 |
| Barclays | Analyst unavailable | $124 | $126.75 | +7.1% | Jul 23, 2026 |
| Barclays | Analyst unavailable | $123 | $123.75 | +6.3% | Jul 14, 2026 |
| UBS | Analyst unavailable | $162 | $129.16 | +40.0% | Apr 24, 2026 |
| Evercore ISI | Stephen Kim | $151 | $129.22 | +30.5% | Apr 24, 2026 |
| Wells Fargo | Analyst unavailable | $140 | $130.64 | +21.0% | Apr 24, 2026 |
| Truist Financial | Analyst unavailable | $150 | $121.33 | +29.6% | Apr 16, 2026 |
| Raymond James | Analyst unavailable | $145 | $130.46 | +25.3% | Feb 4, 2026 |
| RBC Capital | Analyst unavailable | $115 | $124.72 | -0.6% | Jan 30, 2026 |
| Oppenheimer | Analyst unavailable | $149 | $127.26 | +28.7% | Jan 30, 2026 |
| Goldman Sachs | Analyst unavailable | $144 | $133.23 | +24.4% | Jan 13, 2026 |
| RBC Capital | Mike Dahl | $111 | $123.16 | -4.1% | Jan 9, 2026 |
| UBS | Analyst unavailable | $159 | $119.86 | +37.4% | Jan 6, 2026 |
| Barclays | Matthew Bouley | $115 | $126.99 | -0.6% | Dec 8, 2025 |
| Evercore ISI | Analyst unavailable | $134 | $123.27 | +15.8% | Oct 22, 2025 |
| Evercore ISI | Analyst unavailable | $154 | $135.48 | +33.1% | Oct 7, 2025 |
| RBC Capital | Mike Dahl | $109 | $101.06 | -5.8% | Apr 23, 2025 |
| UBS | John Lovallo | $141 | $101.06 | +21.8% | Apr 23, 2025 |
| Barclays | Matthew Bouley | $98 | $101.06 | -15.3% | Apr 23, 2025 |
| Wedbush | Jay McCanless | $135 | $110.01 | +16.7% | Jan 3, 2025 |
| Wells Fargo | Sam Reid | $165 | $139.44 | +42.6% | Oct 7, 2024 |
| Bank of America Securities | Rafe Jadrosich | $160 | $140.99 | +38.3% | Sep 19, 2024 |
| Wells Fargo | Sam Reid | $150 | $125.67 | +29.6% | Jul 24, 2024 |
| Barclays | Matthew Bouley | $131 | $113.84 | +13.2% | Jul 12, 2024 |
| Oppenheimer | Tyler Batory | $143 | $114.2 | +23.6% | May 22, 2024 |
| Raymond James | Buck Horne | $135 | $108.09 | +16.7% | Apr 25, 2024 |
| Barclays | Matthew Bouley | $136 | $116.48 | +17.5% | Apr 4, 2024 |
| Wolfe Research | Truman Patterson | $64 | $55.94 | -44.7% | Mar 23, 2023 |
| Barclays | Matthew Bouley | $75 | $58.8 | -35.2% | Feb 5, 2023 |
| J.P. Morgan | Analyst unavailable | $74 | $60.11 | -36.1% | Feb 2, 2023 |
| Citigroup | Analyst unavailable | $68 | $59.33 | -41.2% | Feb 2, 2023 |
| RBC Capital | Analyst unavailable | $54 | $56.83 | -53.3% | Feb 1, 2023 |
| Wedbush | Analyst unavailable | $57 | $56.56 | -50.7% | Feb 1, 2023 |
| BTIG | Analyst unavailable | $68 | $56.53 | -41.2% | Feb 1, 2023 |
| Oppenheimer | Analyst unavailable | $68 | $56.96 | -41.2% | Feb 1, 2023 |
| Goldman Sachs | Analyst unavailable | $50 | $50.46 | -56.8% | Jan 12, 2023 |
| Barclays | Analyst unavailable | $58 | $45.79 | -49.9% | Dec 14, 2022 |
| BTIG | Analyst unavailable | $61 | $43.28 | -47.3% | Dec 6, 2022 |
| Raymond James | Analyst unavailable | $59 | $43.66 | -49.0% | Jul 28, 2022 |
| Barclays | Matthew Bouley | $48 | $44.7 | -58.5% | Jul 26, 2022 |
| J.P. Morgan | Analyst unavailable | $49.5 | $44.06 | -57.2% | Jul 12, 2022 |
| RBC Capital | Mike Dahl | $41 | $37.92 | -64.6% | Jun 22, 2022 |
| Citigroup | Analyst unavailable | $43 | $36.25 | -62.8% | Jun 21, 2022 |
| Wells Fargo | Analyst unavailable | $41 | $35.16 | -64.6% | Jun 17, 2022 |
| UBS | Analyst unavailable | $55 | $39.43 | -52.5% | Jun 16, 2022 |
| RBC Capital | Analyst unavailable | $56 | $43.56 | -51.6% | Apr 29, 2022 |
| Wells Fargo | Deepa Raghavan | $52 | $50.27 | -55.1% | Nov 15, 2021 |
| Raymond James | Buck Horne | $70 | $48.46 | -39.5% | Oct 27, 2021 |
| Goldman Sachs | Susan Maklari | $58 | $49.09 | -49.9% | Sep 8, 2021 |
| Janney Montgomery | Tyler Batory | $71 | $58.02 | -38.7% | Apr 28, 2021 |
Track every rating change on PHM the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationPulteGroup, Inc. engages in the homebuilding business. The firm is also involved in mortgage banking and title and insurance brokerage operations. It operates through the Homebuilding and Financial services business segments. The Homebuilding segment includes operations from Connecticut, Maryland, Massachusetts, New Jersey, New York, Pennsylvania, Virginia, Georgia, North Carolina, South Carolina, Tennessee, Florida, Illinois, Indiana, Kentucky, Michigan, Minnesota, Missouri, Ohio, Texas, Arizona, California, Nevada, New Mexico, and Washington. The Financial Services segment is composed of mortgage banking and title operations. The company was founded by William J. Pulte in 1950 and is headquartered in Atlanta, GA.
Historical context
All PHM earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| NKE NIKE, Inc. | FY2027 Q1 · Calendar Q4 2026 | +10.0% | -0.7% | Nike’s performance categories grow as resets weigh on FY27 outlook |
| CCL Carnival Corporation & plc | FY2026 Q3 · Calendar Q3 2026 | +5.9% | +13.4% | Carnival posts record Q3 as demand and efficiency offset fuel costs |
| DRI Darden Restaurants, Inc. | FY2027 Q1 · Calendar Q3 2026 | 0.0% | -3.0% | Darden reaffirms FY2027 outlook as brands deliver mixed comp growth |
| AZO AutoZone, Inc. | FY2026 Q4 · Calendar Q3 2026 | +3.6% | +3.3% | AutoZone pairs commercial momentum with an aggressive FY2027 expansion plan |
| LEN-B Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | — | Lennar: Efficiency Gains Offset Housing-Market Pressures |
| LEN Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | -4.1% | Lennar Holds Volume Guidance as Margins Improve Despite Housing Headwinds |
Latest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the PHM recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:36:15.940040+00:00
- Polygon adjusted daily market bars · 2026-10-03T04:26:07.768742+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-03T04:26:07.765851+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-03. For educational purposes only; not investment advice.